Results for the substance encorafenib

Encorafenib is a medication used to treat certain types of cancer, particularly metastatic or advanced melanoma with a BRAF V600 mutation. It is usually used in combination with other medications, such as binimetinib.

This medication works by inhibiting the mutant BRAF protein, which plays a key role in the growth and spread of cancer cells. By blocking this protein, encorafenib helps slow the progression of cancer.

Encorafenib may cause side effects, including nausea, fatigue, diarrhea, or skin rashes. In rare cases, more severe reactions such as liver function impairment or heart problems may occur.

It is important to follow your doctor's instructions closely and report any side effects. Regular monitoring is necessary to assess the treatment's effectiveness and manage potential side effects.